Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Melanotan-I

Afamelanotide, MT-I, [Nle4-D-Phe7]-α-MSH, Scenesse, CUV-1647

Quick Stats
Studies 225
Trials 100
Score 3
2008 pubmed 30 citations

Leptin infusion and obesity in mouse cause alterations in the hypothalamic melanocortin system.

Gout. Johann J; Sarafian. Delphine D; Tirard. Julien J; Blondet. Antonine A; Vigier. Michèle M; Rajas. Fabienne F; Mithieux. Gilles G; Begeot. Martine M; Naville. Danielle D

Key Findings

  • Leptin raises POMC and MC4R gene activity in healthy mice
  • Obese mice develop leptin resistance; early obesity lowers POMC and AgRP without changing MC4R
  • Long‑term obesity with diabetes dramatically increases MC4R expression, hinting at leptin‑independent regulation

Practical Outcomes

  • Leptin supplements are unlikely to aid weight loss once leptin resistance sets in. Directly activating MC4R (e.g., with melanotan‑I or similar agents) might bypass this block, but human evidence is missing. Biohackers should focus on preventing leptin resistance through diet and lifestyle rather than relying on leptin alone.

Summary

In normal mice, giving leptin boosts brain signals (POMC and MC4R) that curb appetite, but obese mice quickly become resistant to leptin, losing those signals while MC4R stays the same early on and spikes later when diabetes develops. This shows the brain’s weight‑control system changes as obesity worsens.

Abstract

The objectives of this study were to identify potential alterations in gene expression of melanocortin-4 receptor (MC4-R), proopiomelanocortin (POMC), and Agouti-related protein (AgRP) in mouse hypothalamus under a chronic peripheral infusion of leptin or at early (8 weeks) and advanced (16 weeks) phases of diet-induced obesity. Control or diet-induced obesity mice (8 or 16 weeks of high-fat diet) were either treated or not treated with leptin. Metabolic features were analyzed and expression of the genes of interest was measured by quantitative reverse transcriptase-PCR (RT-qPCR) and western blot. We reported that in control mice, but not in obese mice, leptin infusion induced an increase in POMC mRNA level as well as in MC4-R mRNA level suggesting that leptin could act directly and/or through alpha-melanocyte-stimulating hormone (alpha-MSH). This hypothesis was reinforced after in vitro studies, using the mouse hypothalamic GT1-7 cell line, since both leptin and Norleucine(4), D-Phenylalanine(7)-alpha-MSH (NDP-alpha-MSH) treatments increased MC4-R expression. After 8 weeks of high-fat diet, nondiabetic obese mice became resistant to the central action of leptin and their hypothalamic content of POMC and AgRP mRNA were decreased without modification of MC4-R mRNA level. After 16 weeks of high-fat diet, mice exhibited more severe metabolic disorders with type 2 diabetes. Moreover, hypothalamic expression of MC4-R was highly increased. In conclusion, several alterations of the melanocortin system were found in obese mice that are probably consecutive to their central resistance to leptin. Moreover, when the metabolic status is highly degraded (with all characteristics of a type 2 diabetes), other regulatory mechanisms (independent of leptin) can also take place.

Study Information

Provider

pubmed

Year

2008

Date

2008-06-12T00:00:00.000Z

DOI

10.1038/oby.2008.303

Citations

30

References

37